A disseminated model of non-Hodgkin's lymphoma with prevalent liver metastasis was generated by intraperitoneal (i.p.) injection of EBV(+) B lymphoblastoid SKW6.4 in nude-SCID mice. The survival of SKW6.4 xenografts (median survival = 27 days) was significantly improved when hyaluronan scaffolds embedded with mesenchimal stem cells (MSC) were implanted in the abdominal area 4 days after SKW6.4 injection (median survival = 39.5 days). Mice implanted with MSC showed a significant improvement of hepatic functionality in lymphoma xenografts, as demonstrated by measurement of serum ALT/AST levels. Co-culture of MSC with lymphoma cells enhanced the release of hepatocyte growth factor (HGF) by MSC. These data suggest that hyaluronan-embedded MSC exert anti-lymphoma activity by ameliorating hepatic functionality.
|Numero di pagine||5|
|Rivista||Investigational New Drugs|
|Stato di pubblicazione||Published - 2012|
All Science Journal Classification (ASJC) codes
- Pharmacology (medical)
Tripodo, C., Zavan, B., Vindigni, V., Zauli, G., Secchiero, P., & Corallini, F. (2012). Mesenchymal stem cells display hepato-protective activity in lymphoma bearing xenografts. Investigational New Drugs.